ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Pharmaceuticals

Alzheimer's trials: Samsung biotech arm joins Taiwan startup

South Korean company seeks to move further up the value chain

Samsung Biologics, a leading South Korean company by market capitalization, plans to build a research center in California as it expands beyond contract manufacturing. (Photo courtesy of Samsung Biologics)

SEOUL -- Samsung Biologics looks to develop a treatment for Alzheimer's disease in partnership with Taiwanese startup Aprinoia Therapeutics, as the South Korean manufacturer moves further up the value chain to attract new clients.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more